El papel de lasffracciones lipídicas, lipoproteínas y apolipoproteínas en preeclampiaa

SERRANO DÍAZ, NORMA CECILIA; ACEVEDO, SANDRA MILENA; OTERO MOTTA, MARÍA TERESA; COLMENARES MEJÍA, CLAUDIA CAROLINA; SEPÚLVEDA JAIME, MELISA TATIANA; FORERO GALVIS, EDGAR HUMBERTO; RODRÍGUEZ ROCHA, WISTON ALBERTO; PÁEZ LEAL, MARÍA CAROLINA.
Rev. MED ; 20(1): 62-73, ene.-jun. 2012. ilus, tab
Artículo en Español | LILACS | ID: lil-669289

Documentos relacionados

  1. Dislipidemias en pacientes diabéticos internados en el Hospital Vicente Corral Moscoso
  2. Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults.
  3. Targeting the vivid facets of apolipoproteins as a cardiovascular risk factor in rheumatoid arthritis.
  4. Alterações hematológicas em felinos com esporotricose cutânea
  5. Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration.
  6. Dislipidemia y riesgo cardiovascular en pacientes con enfermedad renal crónica
  7. Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping.
  8. Serum apolipoproteins (apoA-1, apoB, and apoB/apoA-1 ratio) for early identification of dyslipidemia in children with CKD.
  9. Management of hypertension and dyslipidemia in Mexico: Evidence, gaps, and approach.
  10. Síndrome Metabólico en pacientes con psoriasis de la Cátedra de Dermatología del Hospital de Clínicas